433 Recurrence Score (RS) and Treatment Decisions in Node-positive (N+), Estrogen Receptor-positive (ER+) Breast Cancer Patients in Israel

Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results

SpringerPlus ◽

10.1186/2193-1801-3-71 ◽

2014 ◽

Vol 3 (1) ◽

Cited By ~ 15

Author(s):

Georgeta Fried ◽

Mor Moskovitz

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Early Breast Cancer ◽

Recurrence Score ◽

Treatment Decisions ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Oncotype Dx Recurrence Score

Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients

Oncotarget ◽

10.18632/oncotarget.16313 ◽

2017 ◽

Vol 8 (24) ◽

pp. 38706-38716 ◽

Cited By ~ 11

Author(s):

Jiayi Wu ◽

Yan Fang ◽

Lin Lin ◽

Xiaochun Fei ◽

Weiqi Gao ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Early Breast Cancer ◽

Recurrence Score ◽

Distribution Patterns ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive

DNA methylation marker and prediction of outcome in node-positive, estrogen-receptor positive breast cancer patients receiving adjuvant anthracyclin-based chemotherapy

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.11046 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 11046-11046

Author(s):

J. W. Martens ◽

O. Hartmann ◽

F. Spyratos ◽

N. Harbeck ◽

M. Schmitt ◽

...

Keyword(s):

Breast Cancer ◽

Dna Methylation ◽

Estrogen Receptor ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Prediction Of Outcome ◽

Methylation Marker ◽

Node Positive ◽

Impact of the 21-gene Recurrence Score assay on the treatment of estrogen receptor-positive, HER2-negative, breast cancer patients with 1-3 positive nodes: A prospective clinical utility study

Clinical Breast Cancer ◽

10.1016/j.clbc.2021.09.004 ◽

2021 ◽

Author(s):

Nathalie LeVasseur ◽

Julia Sun ◽

David Fenton ◽

Simon Baxter ◽

Angela Chan ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Clinical Utility ◽

Recurrence Score ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

The Breast ◽

10.1016/s0960-9776(17)30297-7 ◽

2017 ◽

Vol 32 ◽

pp. S92-S93

Author(s):

A. Gasol Cudos ◽

S. Morales Murillo ◽

M.J. Panades Siurana ◽

F. Vilardell Villellas ◽

C. Canosa Morales ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrence Score ◽

Treatment Decisions ◽

Oncotype Dx ◽

Single Institution ◽

Node Positive ◽

Oncotype Dx Recurrence Score

The Preoperative Neutrophil/Lymphocyte Ratio Does not Correlate with the 21-Gene Recurrence Score in Estrogen Receptor-Positive Breast Cancer Patients

Oncology Research and Treatment ◽

10.1159/000370341 ◽

2015 ◽

Vol 38 (1-2) ◽

pp. 24-27 ◽

Cited By ~ 1

Author(s):

Tal Grenader ◽

Yevgeni Plotkin ◽

David B. Geffen

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Recurrence Score ◽

Breast Cancer Patients ◽

Neutrophil Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Abstract P2-05-36: Clinicopathological predictors for low risk recurrence distinguished by 21-gene recurrence score in estrogen receptor-positive invasive breast cancer patients

10.1158/1538-7445.sabcs16-p2-05-36 ◽

2017 ◽

Author(s):

Y Tsuchida ◽

N Hayashi ◽

F Omata ◽

H Yamauchi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Invasive Breast Cancer ◽

Recurrence Score ◽

Low Risk ◽

Breast Cancer Patients ◽

Risk Recurrence

Abstract P1-07-14: Real-life analysis evaluating >1000 N0/N1mi estrogen receptor (ER)+ breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score (RS) result: Clinical outcomes with median follow up of > 9 years

10.1158/1538-7445.sabcs17-p1-07-14 ◽

2018 ◽

Author(s):

SM Stemmer ◽

S Rizel ◽

M Steiner ◽

DB Geffen ◽

L Soussan-Gutman ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Clinical Outcomes ◽

Real Life ◽

Recurrence Score ◽

Treatment Decisions ◽

Breast Cancer Patients ◽

Life Analysis

The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration

Cancer Reports ◽

10.1002/cnr2.1431 ◽

2021 ◽

Author(s):

Sirus Djahansouzi ◽

Bettina Hanstein ◽

Daniel Rein ◽

Michel Clees ◽

Werner Rath

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tumor Progression ◽

Cancer Patients ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Receptor Conversion ◽

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting

Molecular Oncology ◽

10.1016/j.molonc.2014.07.003 ◽

2014 ◽

Vol 8 (8) ◽

pp. 1679-1689 ◽

Cited By ~ 11

Author(s):

Anieta M. Sieuwerts ◽

Maria B. Lyng ◽

Marion E. Meijer-van Gelder ◽

Vanja de Weerd ◽

Fred C.G.J. Sweep ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Gene Signatures ◽